Pharmacia & Upjohn, Inc.

Overview

Pharmacia & Upjohn, Inc. was a major pharmaceutical company formed by the merger of Pharmacia AB and The Upjohn Company. It was later acquired by Pfizer Inc., a global leader in the pharmaceuticals sector. The company was known for its contributions to the development of innovative therapies in various therapeutic areas.

Therapeutic areas

API / Drug Master Files

Pharmacia & Upjohn, Inc. holds 1 active (38 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CLINDAMYCIN PALMITATE HYDROCHLORIDE USP KALAMAZOOActive1998-09-01
• DIHYDROFLUOCINOLONE ACETONIDEInactive2002-08-09
• DOXORUBICIN HCLInactive2001-07-03
• VIDARABINEInactive1998-09-01
• TETRACYCLINE HYDROCHLORIDEInactive1998-09-01
• AMPICILLIN SODIUMInactive1998-09-01
• ERYTHROMYCIN STEARATEInactive1998-09-01
• ERYTHROMYCINInactive1998-09-01
• 9-AMINOCAMPTOTHECIN ACTIVE DRUG SUBSTANCEInactive1995-02-07
• MANUFACTURING SITE, FACILITIES, PERSONNLE, AND GENERAL OPERATING PROCEDURES OF NICOTINE CONTAINING PRODUCTS IN HELSINGBORG, SWEDEN.Inactive1993-12-15
• BIZELESIN (U-77779) DRUG SUBSTANCEInactive1993-11-09
• FACILITY, PERSONNEL AND OPERATING PROCEDURES IN STOCKHOLM, SWEDENInactive1993-07-30
• 17-DESOXY OXIDOInactive1993-07-28
• FACILITY AND OPERATING PROCEDURES IN STOCKHOLM, SWEDENInactive1993-07-12
• FACILITY AND OPERATING PROCEDURES IN STRANGNAS, SWEDENInactive1993-07-12

Showing 15 of 38 Drug Master Files.

FDA compliance signals